FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

386977009: Daclizumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2003. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
1461155012 Daclizumab (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
1481091011 Daclizumab en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Daclizumab Is a Monoclonal antibody agent false Inferred relationship Existential restriction modifier
Daclizumab Is a Murine-human monoclonal immunoglobulin G antibody false Inferred relationship Existential restriction modifier
Daclizumab Has disposition Murine-human monoclonal immunoglobulin G antibody false Inferred relationship Existential restriction modifier
Daclizumab Has disposition Immunomodulator true Inferred relationship Existential restriction modifier
Daclizumab Is a Immunosuppressant true Inferred relationship Existential restriction modifier
Daclizumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing daclizumab Has active ingredient True Daclizumab Inferred relationship Existential restriction modifier 1
Daclizumab 25mg/5 mL solution Has active ingredient False Daclizumab Inferred relationship Existential restriction modifier
Daclizumab 25mg/5mL infusion concentrate Has active ingredient False Daclizumab Inferred relationship Existential restriction modifier
Daclizumab 25mg/5mL conventional release solution for injection Has active ingredient False Daclizumab Inferred relationship Existential restriction modifier
Daclizumab Has active ingredient True Daclizumab Inferred relationship Existential restriction modifier 1
Product containing only daclizumab in parenteral dose form (medicinal product form) Has active ingredient True Daclizumab Inferred relationship Existential restriction modifier 1
Product containing daclizumab in parenteral dose form (medicinal product form) Has active ingredient True Daclizumab Inferred relationship Existential restriction modifier 1
Daclizumab 25mg/5mL infusion concentrate - product Has active ingredient False Daclizumab Inferred relationship Existential restriction modifier
Zenapax 25mg/5mL infusion concentrate Has active ingredient False Daclizumab Inferred relationship Existential restriction modifier
Zenapax 25mg/5ml solution for injection vials (Roche Products Ltd) Has active ingredient True Daclizumab Inferred relationship Existential restriction modifier
Daclizumab 25mg/5ml solution for injection vials 3 vial Has active ingredient False Daclizumab Inferred relationship Existential restriction modifier
Zenapax 25mg/5ml solution for injection vials (Roche Products Ltd) 3 vial 3 x 5ml vials Has active ingredient False Daclizumab Inferred relationship Existential restriction modifier
Zenapax 25mg/5ml solution for injection vials (Roche Products Ltd) Has specific active ingredient True Daclizumab Inferred relationship Existential restriction modifier
Daclizumab 25mg/5mL infusion concentrate Has specific active ingredient False Daclizumab Inferred relationship Existential restriction modifier
Zenapax 25mg/5ml solution for injection vials (Roche Products Ltd) 3 vial 3 x 5ml vials Has specific active ingredient True Daclizumab Inferred relationship Existential restriction modifier
Daclizumab 25mg/5ml solution for injection vials 3 vial Has specific active ingredient True Daclizumab Inferred relationship Existential restriction modifier
Daclizumab 150mg/1ml solution for injection pre-filled disposable devices Has active ingredient False Daclizumab Inferred relationship Existential restriction modifier
Daclizumab 150mg/1ml solution for injection pre-filled disposable devices Has specific active ingredient True Daclizumab Inferred relationship Existential restriction modifier
Zinbryta 150mg/1ml solution for injection pre-filled pens (Biogen Idec Ltd) Has active ingredient True Daclizumab Inferred relationship Existential restriction modifier
Zinbryta 150mg/1ml solution for injection pre-filled pens (Biogen Idec Ltd) Has specific active ingredient True Daclizumab Inferred relationship Existential restriction modifier
Daclizumab 150mg/1ml solution for injection pre-filled disposable devices 1 pre-filled disposable injection Has specific active ingredient True Daclizumab Inferred relationship Existential restriction modifier
Zinbryta 150mg/1ml solution for injection pre-filled pens (Biogen Idec Ltd) 1 pre-filled disposable injection Has specific active ingredient True Daclizumab Inferred relationship Existential restriction modifier
Daclizumab 25mg/5ml solution for infusion vials Has active ingredient False Daclizumab Inferred relationship Existential restriction modifier
Daclizumab 25mg/5ml solution for infusion vials Has specific active ingredient False Daclizumab Inferred relationship Existential restriction modifier
Daclizumab 25mg/5ml solution for infusion vials Has active ingredient False Daclizumab Inferred relationship Existential restriction modifier
Daclizumab 25mg/5ml solution for infusion vials Has specific active ingredient True Daclizumab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start